Looking forward to seeing you at BOS Manchester 2024
APC & VLE Therapeutics is looking forward to seeing you at Biotech Outsourcing Strategies on November 26-27th, 2024 in Manchester!
Cutting edge process development insights and news from APC.
APC & VLE Therapeutics is looking forward to seeing you at Biotech Outsourcing Strategies on November 26-27th, 2024 in Manchester!
Decoupling process development from manufacturing enhances control, flexibility and innovation - accelerating time to market and reducing risks in pharmaceutical development.
We will be at booth #99 Oct 29-31, 2024 in Barcelona to discuss your vaccine development and manufacturing challenges. Don't miss the technical presentation from our experts.
APC & VLE Therapeutics is looking forward to seeing you at BIO-Europe, in Sweden.
Join us at Biomanufacturing World Summit, San Diego at booth # 13 to meet one-on-one and discuss your development and manufacturing challenges and our approach to accelerating your medicines through CMC hurdles.
Michael Jordan is widely regarded as the greatest basketball player of all time. But beyond his athletic prowess, his philosophy offers invaluable lessons for CMC professionals. Discover how the principles that guided MJ’s legendary career can be applied in pharmaceutical manufacturing.
In this webinar, Guangyang Hou, a Senior Process Development Engineer at APC, explores how model-supported approaches in conjunction with the implementation of Process Analytical Technologies (PAT) and continuous processing, can minimize human intervention whilst drastically reducing development times.
In this webinar, we will explore the development of a 2nd generation downstream process for a complex biotherapeutic and discuss strategies to significantly reduce the number of unit operations, increase yields, reduce costs, and accelerate time-to-market while meeting CQA specifications.
[PANEL DISCUSSION] CMC data is often fragmented, siloed and lacks context - causing regulatory bottlenecks, manufacturing delays & quality issues.
Using data-rich experimentation and mixing models, which leverage CFD, a right-first scale up of the new process was achieved within the yield improvements translating directly back to the plant.